Troponin I, cardiac muscle (TNNI3) (TNNI3)

Troponin I, cardiac muscle (TNNI3) is a protein that serves as the inhibitory subunit of the troponin complex, which is essential for the calcium-dependent regulation of striated muscle contraction in the heart (UniProt P19429). It functions by blocking the interaction between actin and myosin filaments in the absence of calcium, thereby preventing muscle contraction during diastole. When calcium levels rise and bind to troponin C, TNNI3 undergoes a conformational shift that releases this inhibition, allowing the heart to contract (PubMed: 25332256). Mutations in the TNNI3 gene are a well-documented cause of familial hypertrophic cardiomyopathy and other cardiac disorders, highlighting its structural and functional importance (NIH: GeneID 7137). In clinical practice, cardiac troponin I is the gold-standard biomarker for the diagnosis of myocardial infarction, as its presence in the blood indicates cardiac myocyte necrosis (StatPearls: Troponin). While it is a primary diagnostic target, it is also a focus of therapeutic research for heart failure. Calcium sensitizers like levosimendan modulate the troponin complex to enhance contractility without increasing intracellular calcium, potentially improving cardiac output (PubChem: CID 3033825). However, targeting this protein requires careful management to avoid pro-arrhythmic effects or impaired diastolic relaxation.

Other names

Cardiac troponin IcTnITroponin I type 3TNNI3TNNC1-interacting protein

Calcium sensitization of the troponin complex to stabilize the active state of the thin filament, enhancing myocardial contractility.